Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of docetaxel, cisplatin and 5-fluorouracil in advanced penile cancer
2008-000707-28Phase 2Completed
- Sponsor
- The Institute of Cancer Research
- Start
- Apr 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel, cisplatin and fluorouracil in penile cancer, sponsored by The Institute of Cancer Research. Primary endpoint: Overall response rate. Started Apr 2009; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
penile cancer
Beyond the preview
Go deeper on 2008-000707-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000707-28.